141 MM-121, an Anti-ErbB3 Antibody, Inhibits PI3K/AKT Signaling and Viability in Platinum-resistant Ovarian Cells and in Primary Ascites Derived From Chemo-resistant Ovarian Cancer Patients

Autor:	A. Fulgham, G. MacBeath, J. Allen, M. Wainszelbaum, Ashish Kalra, D. Xiao, M. Curley, G. Garcia, W. Kubasek
Rok vydání:	2012
Předmět:	Oncology Cancer Research medicine.medical_specialty Pi3k akt signaling biology business.industry medicine.disease Internal medicine Ascites medicine biology.protein Cancer research ERBB3 Antibody medicine.symptom Ovarian cancer business Platinum resistant
Zdroj:	European Journal of Cancer. 48:43-44
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1b9061d6d5fd7790298cea62b39164cd https://doi.org/10.1016/s0959-8049(12)71939-1 Zobrazit plný text záznamu Full Text from ScienceDirect